Our commitment to environmental sustainability at Takeda builds on almost 50 years of engaging in environmental stewardship initiatives since establishing an Environmental Protection Committee in 1970. Our approach to environmental sustainability, which is in line with the UN Sustainable Goals and the Science Based Targets initiative (SBTi), is part of our mission to strive towards Better Health and a Brighter Future for people worldwide.
Risks to the natural environment are also intensifying risks to human health, including infectious diseases made worse by climate change. Our values guide us in our commitment to protect the environment and our patients and motivate us to act urgently.
Our Carbon Neutrality Strategy will build on the progress we’ve made from prior environmental commitments and allow us to continue making a difference in reducing the effects of climate change. Takeda has been advancing environmental sustainability for many years through its efforts in areas such as water and energy conservation, and protection of biodiversity.
As part of our Carbon Neutrality Commitment, we are aiming to become carbon zero in our own operations by 2040 by eliminating 100% of our greenhouse gas emissions.
We’ve met several environmental targets early that were set in 2015 to be completed by 2020 and will build on our progress as we work to protect the health of the planet and contribute to the global, collective effort against climate change.
In 2020 we established new waste and water targets which follow our early completion of prior waste and water consumption goals. We aim to achieve zero waste to landfill status by 2030 for all major locations and a 5% reduction in water consumption by FY2025 (relative to FY2019) levels. Until 2021 we will execute water risk assessments at our manufacturing sites and develop a risk-based approach to water management and replenishment.
We aim to minimize the environmental impact of products and services based on the principles of a circular economy.
In 2020 we relaunched our product stewardship program which focuses on evaluating products and processes for opportunities to minimize their environmental impact, e.g., green chemistry, resource efficiency, recyclable packaging. To do so we perform regular assessments of our product portfolio to identify ways for reducing risks of pharmaceuticals in the environment, e.g., toxicity of waste or wastewater discharge.
“We have a continuing commitment as an industry focused on public health to set an example and lead in protecting our climate and environment.”
/Teresa Bitetti, Global President Oncology, Takeda
“Throughout our global manufacturing operation and supply chain, we are constantly working to reduce the environmental impact of our production.”
/Thomas Wozniewski, Global Manufacturing & Supply Officer
“We recognize the well-documented link between climate change and public health, and honor our responsibility to protect the environment.”
/Deborah Donovan, Global Head of Corporate Environment, Health and Safety